文献速递心律失常瓣膜病与结构性心脏病心力衰竭与心肌病

先天性心脏病中的心源性猝死

Sudden cardiac death in congenital heart disease.
PubMed 文献 · Eur Heart J · 2022-01-01

该文综述先天性心脏病(CHD)患者心源性猝死(SCD)占死亡比例高达25%,指出当前研究多为观察性且存在定义不一、分类不完整等局限。识别的高危基质包括法洛四联症、大动脉转位、紫绀型心脏病、Ebstein畸形和Fontan循环。无尸检时难以区分SCD与非心脏性猝死,无脉电活动/心脏停搏占比较高,复律成功率受肺动脉高压和CHD复杂度影响。皮下ICD在特定患者中成为经静脉系统的替代选择。

要点

  • CHD患者SCD占死亡可达25%,法洛四联症、大动脉转位、紫绀型心脏病、Ebstein畸形和Fontan循环为高危基质。
  • 无尸检难以区分SCD与非心脏性猝死,无脉电活动/心脏停搏占SCD较高比例,尤其在心衰患者。
  • 肺动脉高压和CHD复杂度与复苏成功率较低相关;皮下ICD适用于血管通路受限、既往装置感染、心内分流或Fontan循环者。

核心结论

  • CHD患者SCD占死亡可达25%,需从疾病过程、分类、高危特征、早期预警、高质量心肺复苏和个体化预防治疗等多维度改善结局。

研究设计与样本

  • 综述,基于观察性研究和真实世界经验,未报告系统检索范围或样本量。

主要发现

  • SCD占CHD患者死亡的比例可达25%。
  • 较高危基质包括法洛四联症、大动脉转位、紫绀型心脏病、Ebstein畸形和Fontan循环。
  • 无脉电活动/心脏停搏占SCD较高比例,尤其在心衰患者中。
  • 肺动脉高压和CHD复杂度与复苏成功可能性较低相关。

关键数值与推荐

  • 一级预防ICD风险分层应考虑可电击心律所致SCD概率、竞争性死亡原因、ICD治疗并发症和相关费用。
  • 皮下ICD可作为经静脉系统的替代选择,适用于血管通路受限、既往装置感染、心内分流或Fontan循环患者。

临床怎么用

  • 对CHD患者应识别高危基质并评估SCD风险,一级预防ICD决策需综合可电击心律概率、竞争性死亡原因、并发症和费用。
  • 血管通路受限、既往装置感染、心内分流或Fontan循环患者可考虑皮下ICD。
  • 强调高质量心肺复苏以改善SCD结局,肺动脉高压和CHD复杂度高者复苏成功率较低需特别关注。

局限性

  • 研究多由观察性研究和真实世界经验驱动,存在定义不一、分类不完整、结局确认不一致和数据粒度有限等局限。
  • 无尸检时难以区分SCD与非心脏性猝死。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sudden cardiac death (SCD) accounts for up to 25% of deaths in patients with congenital heart disease (CHD). To date, research has largely been driven by observational studies and real-world experience. Drawbacks include varying definitions, incomplete taxonomy that considers SCD as a unitary diagnosis as opposed to a terminal event with diverse causes, inconsistent outcome ascertainment, and limited data granularity. Notwithstanding these constraints, identified higher-risk substrates include tetralogy of Fallot, transposition of the great arteries, cyanotic heart disease, Ebstein anomaly, and Fontan circulation. Without autopsies, it is often impossible to distinguish SCD from non-cardiac sudden deaths. Asystole and pulseless electrical activity account for a high proportion of SCDs, particularly in patients with heart failure. High-quality cardiopulmonary resuscitation is essential to improve outcomes. Pulmonary hypertension and CHD complexity are associated with lower likelihood of successful resuscitation. Risk stratification for primary prevention implantable cardioverter-defibrillators (ICDs) should consider the probability of SCD due to a shockable rhythm, competing causes of mortality, complications of ICD therapy, and associated costs. Risk scores to better estimate probabilities of SCD and CHD-specific guidelines and consensus-based recommendations have been proposed. The subcutaneous ICD has emerged as an attractive alternative to transvenous systems in those with vascular access limitations, prior device infections, intra-cardiac shunts, or a Fontan circulation. Further improving SCD-related outcomes will require a multidimensional approach to research that addresses disease processes and triggers, taxonomy to better reflect underlying pathophysiology, high-risk features, early warning signs, access to high-quality cardiopulmonary resuscitation and specialized care, and preventive therapies tailored to underlying mechanisms.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Khairy P, Silka MJ, Moore JP, et al. Sudden cardiac death in congenital heart disease. Eur Heart J. 2022. PMID: 35302168. doi:10.1093/eurheartj/ehac104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。